Earth Science Tech, Inc. (ETST)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Earth Science Tech, Inc. (ETST) with AI Score 61/100 (Hold). Earth Science Tech, Inc. is a biotechnology company focused on developing and delivering nutraceuticals, bioceuticals, and dietary supplements. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026Earth Science Tech, Inc. (ETST) Healthcare & Pipeline Overview
Earth Science Tech, Inc. operates in the healthcare sector, focusing on nutraceuticals and dietary supplements for various health conditions. With a market capitalization of $0.03 billion and a P/E ratio of 9.88, the company distributes its products through retail, clinics, pharmacies, and online channels, competing in a fragmented market.
Investment Thesis
Earth Science Tech, Inc. presents a speculative investment opportunity within the nutraceutical and dietary supplement market. With a market capitalization of $0.03 billion and a P/E ratio of 9.88, the company's valuation reflects both its growth potential and inherent risks associated with OTC-listed companies. A gross margin of 65.1% indicates strong pricing power, while a profit margin of 10.0% demonstrates profitability. Growth catalysts include expanding its online presence and developing new formulations for existing products. However, potential risks include the company's reliance on a limited product line and the competitive nature of the nutraceutical market. The company's high beta of 2.02 suggests significant volatility, making it suitable for investors with a high-risk tolerance. The lack of dividend yield further emphasizes its growth-oriented profile.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.03 billion indicates a small-cap company with potential for growth but also higher risk.
- P/E ratio of 9.88 suggests the company is potentially undervalued compared to its earnings.
- Gross margin of 65.1% reflects strong pricing power and efficient cost management.
- Profit margin of 10.0% demonstrates the company's ability to generate profit after all expenses.
- Beta of 2.02 indicates high volatility compared to the market, suggesting higher risk and potential reward.
Competitors & Peers
Strengths
- Diverse product line targeting various health conditions.
- Multi-channel distribution network.
- Strong gross margin indicating pricing power.
- Focus on natural and alternative health solutions.
Weaknesses
- Small market capitalization and limited financial resources.
- High beta indicating significant volatility.
- Reliance on a limited number of key products.
- Limited brand recognition compared to larger competitors.
Catalysts
- Potential new product launches in the nutraceutical and dietary supplement market.
- Expansion of online presence and e-commerce sales channels.
- Strategic partnerships with clinics, pharmacies, and healthcare providers.
Risks
- Intense competition from larger and more established companies in the nutraceutical industry.
- Changing regulations and compliance requirements affecting the dietary supplement market.
- Fluctuations in raw material prices impacting the company's profitability.
- Limited financial resources and small market capitalization.
- High beta indicating significant price volatility.
Growth Opportunities
- Expanding Online Presence: ETST can capitalize on the growing e-commerce trend by enhancing its online platform and digital marketing efforts. The global e-commerce market is projected to reach trillions of dollars in the coming years, offering a significant opportunity for ETST to increase its sales and market reach. By investing in SEO, social media marketing, and targeted advertising, ETST can attract new customers and drive online sales, with an expected impact within the next 1-2 years.
- Developing New Formulations: ETST can invest in research and development to create new and innovative formulations for its existing products. The nutraceutical industry is constantly evolving, with new ingredients and delivery methods emerging regularly. By staying ahead of the curve and developing unique and effective formulations, ETST can differentiate itself from competitors and attract health-conscious consumers. This could lead to new product launches within the next 18-24 months.
- Strategic Partnerships: ETST can form strategic partnerships with clinics, pharmacies, and healthcare providers to expand its distribution network and reach a wider audience. Collaborating with established healthcare professionals can enhance ETST's credibility and build trust with consumers. These partnerships could be established within the next year, leading to increased sales and market penetration.
- Geographic Expansion: ETST can explore opportunities to expand its operations into new geographic markets, particularly in regions with a growing demand for nutraceuticals and dietary supplements. Emerging markets in Asia and Latin America offer significant growth potential. By conducting market research and adapting its products to local preferences, ETST can successfully enter new markets and diversify its revenue streams over the next 2-3 years.
- Focus on Specific Health Conditions: ETST can focus its marketing efforts on specific health conditions, such as chronic pain, joint pain, and inflammation. By targeting consumers with specific health needs, ETST can increase its brand awareness and build a loyal customer base. This targeted approach can be implemented within the next 6-12 months, leading to improved marketing ROI and increased sales.
Opportunities
- Expanding online presence and e-commerce sales.
- Developing new and innovative product formulations.
- Forming strategic partnerships with healthcare providers.
- Entering new geographic markets with growing demand for nutraceuticals.
Threats
- Intense competition from larger and more established companies.
- Changing regulations and compliance requirements.
- Fluctuations in raw material prices.
- Negative publicity or adverse events affecting the nutraceutical industry.
Competitive Advantages
- Proprietary formulations and unique product offerings.
- Established distribution network through multiple channels.
- Brand recognition and customer loyalty in specific market segments.
About ETST
Earth Science Tech, Inc. (ETST) is a biotechnology company that develops, markets, and distributes nutraceuticals, bioceuticals, and dietary supplements. Founded in 2010 and formerly known as Ultimate Novelty Sports, Inc., the company rebranded in March 2014 to focus on health and wellness products. Headquartered in Doral, Florida, ETST offers a range of products targeting chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging, and overall wellness. The company's product portfolio includes hemp oils, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods, and other products. These are available in various formulations such as capsules, tablets, soft gels, chewables, liquids, creams, sprays, and powders. ETST distributes its products through multiple channels, including its retail store, clinics, pharmacies, and online platforms. This multi-channel approach aims to maximize market reach and cater to diverse customer preferences. ETST also provides medical equipment and devices, further diversifying its offerings within the healthcare sector. The company operates with 32 employees and aims to expand its market presence through innovative product development and strategic distribution partnerships.
What They Do
- Develops and markets nutraceuticals and bioceuticals.
- Offers dietary supplements for various health conditions.
- Provides products targeting chronic pain, joint pain, and inflammation.
- Distributes hemp oils, vitamins, minerals, and herbs.
- Sells personal care products, homeopathies, and functional foods.
- Offers medical equipment and devices.
Business Model
- Develops and manufactures nutraceutical and dietary supplement products.
- Distributes products through retail stores, clinics, pharmacies, and online channels.
- Generates revenue through the sale of its products to consumers and healthcare providers.
Industry Context
Earth Science Tech, Inc. operates within the growing nutraceutical and dietary supplement industry. This market is characterized by increasing consumer awareness of health and wellness, driving demand for natural and alternative health solutions. The industry is highly competitive, with numerous players ranging from large pharmaceutical companies to smaller, specialized firms. ETST competes with companies offering similar products, focusing on specific health conditions and distribution channels. The global nutraceutical market is expected to continue growing, driven by aging populations and rising healthcare costs.
Key Customers
- Individuals seeking natural health and wellness solutions.
- Patients with chronic pain, joint pain, and inflammation.
- Healthcare providers recommending supplements to their patients.
- Consumers interested in vitamins, minerals, and herbal remedies.
ETST Financials
ETST Price Today & Live Chart
Earth Science Tech, Inc. (ETST) stock price: Price data unavailable
ETST Latest News
-
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
benzinga · Dec 18, 2025
-
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
benzinga · Dec 17, 2025
-
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
benzinga · Aug 5, 2025
-
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
benzinga · Jun 10, 2025
ETST Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ETST.
Price Targets
Wall Street price target analysis for ETST.
ETST MoonshotScore
What does this score mean?
The MoonshotScore rates ETST's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
Leadership: Giorgio R. Saumat
CEO
Giorgio R. Saumat serves as the Chief Executive Officer of Earth Science Tech, Inc. His background includes experience in managing and growing businesses, with a focus on strategic planning and operational efficiency. He is responsible for overseeing the company's overall strategy, product development, and market expansion efforts. His leadership aims to drive innovation and growth within the nutraceutical and dietary supplement market.
Track Record: Under Giorgio R. Saumat's leadership, Earth Science Tech, Inc. has focused on expanding its product line and distribution channels. Key achievements include the development of new formulations and the establishment of strategic partnerships. His tenure has been marked by efforts to increase brand awareness and market penetration within the competitive nutraceutical industry.
ETST OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Earth Science Tech, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Lower trading volumes and liquidity.
- Greater price volatility and potential for manipulation.
- Higher risk of fraud or mismanagement.
- Limited regulatory oversight and investor protection.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's OTC Markets profile and disclosure history.
- Check for any regulatory actions or legal proceedings involving the company.
- Consult with a qualified financial advisor before investing.
- Understand the risks associated with investing in OTC stocks.
- Company has been in operation since 2010.
- Company has a diverse product line targeting various health conditions.
- Company distributes products through multiple channels, including retail stores and online platforms.
Common Questions About ETST (Healthcare)
What does Earth Science Tech, Inc. do?
Earth Science Tech, Inc. is a biotechnology company focused on developing, marketing, and distributing nutraceuticals, bioceuticals, and dietary supplements. The company offers a range of products targeting various health conditions, including chronic pain, joint pain, inflammation, and overall wellness. These products are available in various formulations and are distributed through retail stores, clinics, pharmacies, and online channels.
What do analysts say about ETST stock?
As of 2026-03-17, there is no available analyst coverage for Earth Science Tech, Inc. due to its OTC listing and small market capitalization. Investors should conduct their own thorough research and consider the risks associated with investing in OTC stocks, including limited liquidity and potential volatility. Key valuation metrics include a P/E ratio of 9.88 and a gross margin of 65.1%.
What are the main risks for ETST?
The main risks for Earth Science Tech, Inc. include intense competition from larger companies, changing regulations in the nutraceutical industry, fluctuations in raw material prices, limited financial resources, and high price volatility. As an OTC-listed company, ETST also faces risks related to limited liquidity, potential for manipulation, and reduced regulatory oversight. Investors should carefully consider these risks before investing.
What are the key factors to evaluate for ETST?
Earth Science Tech, Inc. (ETST) currently holds an AI score of 61/100, indicating moderate score. Key strength: Diverse product line targeting various health conditions. Primary risk to monitor: Intense competition from larger and more established companies in the nutraceutical industry. This is not financial advice.
How frequently does ETST data refresh on this page?
ETST prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ETST's recent stock price performance?
Recent price movement in Earth Science Tech, Inc. (ETST) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diverse product line targeting various health conditions. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ETST overvalued or undervalued right now?
Determining whether Earth Science Tech, Inc. (ETST) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ETST?
Before investing in Earth Science Tech, Inc. (ETST), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- OTC market data may be less reliable than data from major exchanges.